Literature DB >> 27194125

Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution.

Ryu Kanzaki1, Masayoshi Inoue2, Masato Minami1, Yasushi Shintani1, Soichiro Funaki1, Tomohiro Kawamura1, Meinoshin Okumura1.   

Abstract

PURPOSE: The aim of this study is to investigate the surgical outcomes of surgery for non-small cell lung cancer (NSCLC) in patients with coronary artery disease (CAD).
METHODS: Among 805 patients who underwent surgery for NSCLC at our hospital within a recent 10-year period, 43 (5.3 %) had a history of CAD. We analyzed the surgical outcomes and risk factors for postoperative complications in these 43 patients.
RESULTS: The postoperative mortality and morbidity rates were 2 and 42 %, respectively. The morbidity rate was significantly higher in the patients with CAD than in those without CAD (P < 0.01). Postoperative cerebrovascular or cardiovascular events occurred in four patients (9 %). Having two of the following was significantly associated with the development of postoperative complications: decreased cardiac function, respiratory dysfunction, or deteriorated renal function (p = 0.04). The 5-year overall and disease-free survival rates of the patients with CAD were 75.6 and 64.5 %, respectively; comparable with those of the patients without CAD; at 77.9 % and 72.5 %, respectively (p = 0.46 and 0.69).
CONCLUSIONS: Patients with NSCLC and a history of CAD are at higher risk of complications after pulmonary resection. Combined decreased organ function is a risk factor for postoperative complications. CAD did not influence the long-term outcomes of patients after pulmonary resection for NSCLC.

Entities:  

Keywords:  Comorbidity; Coronary artery disease; Lung cancer; Surgery

Mesh:

Year:  2016        PMID: 27194125     DOI: 10.1007/s00595-016-1355-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  21 in total

Review 1.  Risk factors predictive of atrial fibrillation after lung cancer surgery.

Authors:  Takekazu Iwata; Kaoru Nagato; Takahiro Nakajima; Hidemi Suzuki; Shigetoshi Yoshida; Ichiro Yoshino
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

2.  Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project.

Authors:  Tomohiro Matsuda; Tomomi Marugame; Ken-ichi Kamo; Kota Katanoda; Wakiko Ajiki; Tomotaka Sobue
Journal:  Jpn J Clin Oncol       Date:  2010-09-06       Impact factor: 3.019

3.  Impact of cardiopulmonary complications of lung cancer surgery on long-term outcomes.

Authors:  Takashi Nojiri; Masayoshi Inoue; Yukiyasu Takeuchi; Hajime Maeda; Yasushi Shintani; Noriyoshi Sawabata; Toshimitsu Hamasaki; Meinoshin Okumura
Journal:  Surg Today       Date:  2014-09-19       Impact factor: 2.549

4.  Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database.

Authors:  Mark Onaitis; Thomas D'Amico; Yue Zhao; Sean O'Brien; David Harpole
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

5.  The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer.

Authors:  Tomoyoshi Takenaka; Masakazu Katsura; Yasunori Shikada; Syuichi Tsukamoto; Sadanori Takeo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

6.  Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population.

Authors:  Ozcan Birim; H Mischa Zuydendorp; Alexander P W M Maat; A Pieter Kappetein; Marinus J C Eijkemans; Ad J J C Bogers
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

7.  Lung cancer and the left internal mammary artery graft.

Authors:  P S Greene; R F Heitmiller
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

8.  Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer.

Authors:  Pankaj Kumar Mishra; Ragini Pandey; Michael J Shackcloth; James McShane; Antony D Grayson; Martyn H Carr; Richard D Page
Journal:  Eur J Cardiothorac Surg       Date:  2008-12-10       Impact factor: 4.191

9.  Thoracoscopic lobectomy for lung cancer after coronary artery bypass grafting using internal thoracic artery.

Authors:  Soichiro Funaki; Masayoshi Inoue; Norihisa Shigemura; Meinoshin Okumura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-21

10.  Feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients: a retrospective study at a single institute in Japan.

Authors:  Ryu Kanzaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Tomoyuki Nakagiri; Soichiro Funaki; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Surg Today       Date:  2014-02-06       Impact factor: 2.549

View more
  9 in total

Review 1.  Modifiable risk factors for patients undergoing lung cancer surgery and their optimization: a review.

Authors:  Sylvain Gagné; Daniel I McIsaac
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis.

Authors:  Takuro Miyazaki; Takuya Yamazaki; Daisuke Nakamura; Shuntaro Sato; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Ryotaro Kamohara; Go Hatachi; Takeshi Nagayasu
Journal:  Surg Today       Date:  2017-04-26       Impact factor: 2.549

3.  Long-Term Outcomes of Pulmonary Resection for Lung Cancer Patients with Chronic Kidney Disease.

Authors:  Yoko Yamamoto; Ryu Kanzaki; Takashi Kanou; Naoko Ose; Soichiro Funaki; Masato Minami; Yasushi Shintani
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

4.  Characteristics and timing of recurrence during postoperative surveillance after curative resection for lung adenocarcinoma.

Authors:  Terumoto Koike; Tatsuya Goto; Akihiko Kitahara; Seijiro Sato; Masayuki Saitoh; Takehisa Hashimoto; Osamu Namura; Masashi Takahashi; Shin-Ichi Toyabe; Masanori Tsuchida
Journal:  Surg Today       Date:  2017-05-04       Impact factor: 2.549

5.  Prevalence of coronary calcification on preoperative computed tomography and its management in thoracic surgery.

Authors:  Ryusuke Machino; Koichiro Shimoyama; Koji Oku; Kazumi Yamasaki; Tsutomu Tagawa
Journal:  Surg Today       Date:  2022-06-13       Impact factor: 2.549

Review 6.  Video-assisted thoracoscopic surgery node dissection for lung cancer treatment.

Authors:  Atsushi Watanabe; Masahiro Miyajima; Taijiro Mishina; Kodai Tsuruta; Yuki Takahashi; Ryunosuke Maki; Makoto Tada
Journal:  Surg Today       Date:  2017-03-11       Impact factor: 2.549

7.  Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities.

Authors:  Keith Sigel; Chung Yin Kong; Sadiq Rehmani; Susan Bates; Michael Gould; Kimberly Stone; Minal Kale; Yeun-Hee Park; Kristina Crothers; Faiz Bhora; Juan Wisnivesky
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

8.  Comorbidities with non-small cell lung cancer: Is there an interdisciplinary consensus needed to qualify patients for surgical treatment?

Authors:  Marta Lembicz; Piotr Gabryel; Beata Brajer-Luftmann; Wojciech Dyszkiewicz; Halina Batura-Gabryel
Journal:  Ann Thorac Med       Date:  2018 Apr-Jun       Impact factor: 2.219

9.  Two cases of lobectomy for lung cancer after transcatheter aortic valve implantation.

Authors:  Hideki Nagata; Ryu Kanzaki; Takashi Kanou; Naoko Ose; Soichiro Funaki; Yasushi Shintani; Masato Minami; Isamu Mizote; Yasushi Sakata; Koichi Maeda; Toru Kuratani; Yoshiki Sawa; Meinoshin Okumura
Journal:  Surg Case Rep       Date:  2018-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.